Opinion|Videos|November 16, 2026

Adults With TK2D: Monitoring, Late-Onset Phenotype, and the Impact of Diagnosis

Adults may appear well until a stressor unmasks disease, and monitoring must respect work and independence. A genetic diagnosis brings validation, an explanation for long-standing limits, and access to dedicated therapy.

In "Adults With TK2D: Monitoring, Late-Onset Phenotype, and the Impact of Diagnosis," Dr. Zolkipli-Cunningham turns to following an adult patient, recognizing late-onset disease, and what diagnosis means.

Dr. Hirano asks what supportive monitoring looks like for the 34-year-old woman. Dr. Zolkipli-Cunningham begins with independence. A patient in her thirties is likely employed and faces challenges with driving, mobility, communication, stability, and eating normally. Monitoring should be multisystem, with neuromuscular neurology and physical, occupational, and speech therapy. A pulmonologist should track lung function, including diaphragm and intercostal strength, and sleep studies should look for hypoventilation or sleep apnea. Gastroenterology and a dietitian follow dysphagia, height, weight, and intake, and raise G-tube discussions when needed. Her institution favors physical therapy assessments of gait, stability, endurance, and strength. She emphasizes sensitivity to missed workdays.

Dr. Hirano then asks how late-onset TK2D is recognized as a distinct phenotype. Dr. Zolkipli-Cunningham contrasts floppy infants and children losing milestones with adults who may have only ptosis and restricted eye movements until a stressor such as influenza or surgery brings larger symptoms. Weakness generally progresses. In adults it may be distal as well as proximal, with facial, eyelid, bulbar, neck, and scapular weakness, low muscle bulk, and a thin build. Severity varies, and respiratory impairment requiring ventilatory support is more likely.

Dr. Hirano asks about the impact of diagnosis. She says the first benefit is validation. Patients who run out of gas walking to the office look well and may not understand their symptoms. A diagnosis explains their limits at work, at school, and at family events. The second benefit is hope, since dedicated approved therapy now exists. Dr. Hirano notes that some patients were told their illness was psychogenic, and they agree a genetic diagnosis is a game changer.

The next episode in this series, "Coordinating Multidisciplinary Care in TK2D: Who Leads the Team?," features the panel discussing who belongs on the team and who should coordinate it.


Related to this article

NeurologyLive® Brain Games: November 15, 2026
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is National Epilepsy Awareness Month!